MMG Announces 2011 “Todos Juntos Por La Salud” Initiative
On Feb. 11, 2011, clinical trial patient recruitment and retention organization MMG will host a groundbreaking forum, “Todos Juntos por la Salud” or “All Together for Health,” which will address the state of Hispanic and Latino participation in medical research. Through this seminal initiative, MMG will partner with Hispanic and Latino healthcare community leaders to improve understanding of the research barriers faced by Hispanics and Latinos and identify strategies for overcoming them.
Although Hispanics and Latinos represent 16 percent of the US population, they constitute only 3 percent of the approximately 260,000 Americans who volunteer to participate in medical research each year. With the US Hispanic population expected to triple by 2050, steps need to be taken now to achieve greater Hispanic and Latino representation in medical research.
The forum will feature Hispanic and Latino community leaders and health industry stakeholders who will discuss the root causes behind the disparities in medical research participation, share ideas about what needs to occur to increase engagement, and strategize about how groups can collaborate to achieve these goals. Forum outcomes will be publicized to raise awareness, promote best practices, and build on the initiative’s momentum.
“We at MMG feel an urgency to address the disparity in clinical research access and participation among the US Hispanic and Latino populations,” said MMG CEO John Benbrook. “MMG is committed to applying our relationships and insights from our daily work to leading efforts that will get at the heart of these issues and drive tangible change."
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
